Gülşen Akman‐Demir

Author

Gülşen Akman‐Demir

Also Known As

Gulsen AKMAN-DEMIR, Gulsen Akman-Demir, Gulsen Akman‐Demir, Gülsen Akman‐Demir, Gülşen AKMAN-DEMİR, Gülşen Akman-Demir, Gülşen Akman‐Demir

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Istanbul University Acıbadem University Istanbul Bilim University University of Oxford Haydarpaşa Numune Eğitim ve Araştırma Hastanesi

About

Gülşen Akman‐Demir is an author at Istanbul University specializing in medicine, neuroimmunology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	24	2.7K
2	Public Health	4	4	716
3	Social Sciences	3	3	166
4	Health Sciences	1	1	896
5	Allergy	1	1	33

Gülşen Akman‐Demir

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Ludwig Kappos, Amit Bar‐Or, Bruce Cree, The Lancet Neurological DisorderClinical NeurologyClinical TrialsSiponimod Versus PlaceboNeurological Monitoring	2018	896
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease Elaine F. Remmers, Fulya Coşan, Yohei Kirino, Nature Genetics InflammationImmunogeneticsMhc ClassImmunodeficienciesImmunology	2010	645
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis Sven Jarius, Jette Frederikson, Patrick Waters, Journal of the Neurological Sciences Ocular DiseasePrognostic ImpactAutoimmune DiseaseOphthalmologyImmunology	2010	168
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders Sven Jarius, Christian Jacobi, J. de Sèze, Multiple Sclerosis Journal	2011	166
Interleukin-6 in neuro-Behçet’s disease: Association with disease subsets and long-term outcome Gülşen Akman‐Demir, Erdem Tüzün, Sema İçöz, Cytokine InflammationCytokineNeurobiology Of DiseaseAutoimmune DiseaseMedicine	2008	125
Neuropsychological follow-up of 12 patients with neuro-Behçet disease Öget Öktem-Tanör, Betül Baykan, Hakan Gürvıt, Journal of Neurology Neuro-behçet DiseaseNeuropsychologyNeurological DisorderClinical NeurologyNeuropsychiatry	1999	100
Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases Güher Saruhan‐Direskeneli, Sibel P. Yentür, Gülşen Akman‐Demir, Journal of Neuroimmunology InflammationOther Neurological DiseasesCytokineAutoimmune DiseaseMedicine	2003	84
Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients Gülşen Akman‐Demir, Erdem Tüzün, Patrick Waters, Journal of Neurology Ocular DiseaseAutoimmune DiseaseOphthalmologyAquaporin-4 Antibody StatusMedicine	2010	75
Pro-inflammatory cellular immune response in Behçet’s disease Ayla Kulaber, İlknur Tuğal-Tutkun, Sibel P. Yentür, Rheumatology International InflammationImmunologyBehçet ’Immune-mediated Inflammatory DiseasesInnate Immunity	2007	62
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes Maciej Juryńczyk, Brian G. Weinshenker, Gülşen Akman‐Demir, Journal of Neurology Autoimmune DiseaseNeurological DisorderDiagnostic ApproachesMedicineResonance	2015	62

Page 1